Company

Merus N.V.

Headquarters: Utrecht, Netherlands

Employees: 87

CEO: Dr. Sven Ante Lundberg M.D.

NASDAQ: MRUS -2.61%

Market Cap

$3.59 Billion

USD as of July 1, 2024

Market Cap History

Merus N.V. market capitalization over time

Evolution of Merus N.V. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Merus N.V.

Detailed Description

Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; and collaboration with Incyte Corporation for the development of MCLA-145. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Merus N.V. has the following listings and related stock indices.


Stock: NASDAQ: MRUS wb_incandescent

Stock: FSX: 2GH wb_incandescent

Details

Headquarters:

Yalelaan 62

Utrecht, 3584 CM

Netherlands

Phone: 31 85 016 2500